Print this page    •   Back to Web version of article

The ADAP Watch

June 25, 2010

ADAPs With Waiting Lists (1,840 Individuals, as of June 24, 2010)

Advertisement

Florida: 361 individuals
Hawaii: 9 individuals
Idaho: 26 individuals
Iowa: 97 individuals
Kentucky: 189 individuals
Louisiana: 59 individuals*
Montana: 21 individuals
North Carolina: 769 individuals
South Carolina: 175 individuals
South Dakota: 22 individuals
Utah: 112 individuals

ADAPs With Other Cost-Containment Strategies (Instituted Since April 1, 2009)

Arizona: reduced formulary
Arkansas: reduced formulary, lowered financial eligibility to 200% of FPL
Colorado: reduced formulary
Illinois: reduced formulary
Iowa: reduced formulary
Kentucky: reduced formulary
Louisiana: capped enrollment, discontinued reimbursement of laboratory assays
Missouri: reduced formulary
North Carolina: reduced formulary
North Dakota: capped enrollment, cap on Fuzeon, lowered financial eligibility to 300% FPL
Utah: reduced formulary, lowered financial eligibility to 250% FPL
Washington: client cost sharing, reduced formulary (for uninsured clients only)

ADAPs Considering New/Additional Cost-Containment Measures (Before March 31, 2011**)

Arizona: waiting list
California: proposed elimination of ADAP services in city and county jails
Florida: reduced formulary, lowered financial eligibility
Illinois: reduced formulary, lowered financial eligibility, monthly expenditure cap
Ohio: reduced formulary, lowered financial eligibility, capped enrollment, client cost sharing, annual and monthly expenditure caps
Oregon: reduced formulary, client cost sharing, annual expenditure cap
Wyoming: reduced formulary

* Louisiana has a capped enrollment on their program. This number is a representation of their current unmet need.
** March 31, 2011 is the end of ADAP FY2010. ADAP fiscal years begin April 1 and end March 31.




This article was provided by National Alliance of State and Territorial AIDS Directors. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art57243.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.